Literature DB >> 18606871

Paraquat exposure reduces nicotinic receptor-evoked dopamine release in monkey striatum.

Kathryn T O'Leary1, Neeraja Parameswaran, Louisa C Johnston, J Michael McIntosh, Donato A Di Monte, Maryka Quik.   

Abstract

Paraquat, an herbicide widely used in the agricultural industry, has been associated with lung, liver, and kidney toxicity in humans. In addition, it is linked to an increased risk of Parkinson's disease. For this reason, we had previously investigated the effects of paraquat in mice and showed that it influenced striatal nicotinic receptor (nAChR) expression but not nAChR-mediated dopaminergic function. Because nonhuman primates are evolutionarily closer to humans and may better model the effects of pesticide exposure in man, we examined the effects of paraquat on striatal nAChR function and expression in monkeys. Monkeys were administered saline or paraquat once weekly for 6 weeks, after which nAChR levels and receptor-evoked [(3)H]dopamine ([(3)H]DA) release were measured in the striatum. The functional studies showed that paraquat exposure attenuated dopamine (DA) release evoked by alpha3/alpha6beta2(*) (nAChR that is composed of the alpha3 or alpha6 subunits, and beta2; the asterisk indicates the possible presence of additional subunits) nAChRs, a subtype present only on striatal dopaminergic terminals, with no decline in release mediated by alpha4beta2(*) (nAChR containing alpha4 and beta2 subunits, but not alpha3 or alpha6) nAChRs, present on both DA terminals and striatal neurons. Paraquat treatment decreased alpha4beta2(*) but not alpha3/alpha6beta2(*) nAChR expression. The differential effects of paraquat on nAChR expression and receptor-evoked [(3)H]DA release emphasize the importance of evaluating changes in functional measures. The finding that paraquat treatment has a negative impact on striatal nAChR-mediated dopaminergic activity in monkeys but not mice indicates the need for determining the effects of pesticides in higher species.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18606871      PMCID: PMC2657317          DOI: 10.1124/jpet.108.141861

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  33 in total

1.  Presynaptic nicotinic receptors modulating dopamine release in the rat striatum.

Authors:  S Wonnacott; S Kaiser; A Mogg; L Soliakov; I W Jones
Journal:  Eur J Pharmacol       Date:  2000-03-30       Impact factor: 4.432

2.  Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum.

Authors:  Michele Zoli; Milena Moretti; Alessio Zanardi; J Michael McIntosh; Francesco Clementi; Cecilia Gotti
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

3.  Loss of nicotinic receptors in monkey striatum after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment is due to a decline in alpha-conotoxin MII sites.

Authors:  Jennifer M Kulak; J Michael McIntosh; Maryka Quik
Journal:  Mol Pharmacol       Date:  2002-01       Impact factor: 4.436

4.  Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum.

Authors:  F M Zhou; Y Liang; J A Dani
Journal:  Nat Neurosci       Date:  2001-12       Impact factor: 24.884

5.  Vulnerability of 125I-alpha-conotoxin MII binding sites to nigrostriatal damage in monkey.

Authors:  M Quik; Y Polonskaya; J M Kulak; J M McIntosh
Journal:  J Neurosci       Date:  2001-08-01       Impact factor: 6.167

6.  Characterization of nicotinic agonist-induced [(3)H]dopamine release from synaptosomes prepared from four mouse brain regions.

Authors:  Sharon R Grady; Karen L Murphy; Jian Cao; Michael J Marks; J Michael McIntosh; Allan C Collins
Journal:  J Pharmacol Exp Ther       Date:  2002-05       Impact factor: 4.030

7.  Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat.

Authors:  Alison L McCormack; Mona Thiruchelvam; Amy B Manning-Bog; Christine Thiffault; J William Langston; Deborah A Cory-Slechta; Donato A Di Monte
Journal:  Neurobiol Dis       Date:  2002-07       Impact factor: 5.996

Review 8.  Paraquat poisonings: mechanisms of lung toxicity, clinical features, and treatment.

Authors:  R J Dinis-Oliveira; J A Duarte; A Sánchez-Navarro; F Remião; M L Bastos; F Carvalho
Journal:  Crit Rev Toxicol       Date:  2008       Impact factor: 5.635

9.  Differential nicotinic receptor expression in monkey basal ganglia: effects of nigrostriatal damage.

Authors:  M Quik; Y Polonskaya; J M McIntosh; J M Kulak
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

10.  Distribution and pharmacology of alpha 6-containing nicotinic acetylcholine receptors analyzed with mutant mice.

Authors:  Nicolas Champtiaux; Zhi-Yan Han; Alain Bessis; Francesco Mattia Rossi; Michele Zoli; Lisa Marubio; J Michael McIntosh; Jean-Pierre Changeux
Journal:  J Neurosci       Date:  2002-02-15       Impact factor: 6.167

View more
  4 in total

1.  Quantitative Structure Activity Relationship between Diazabicyclo[4.2.0]octanes Derivatives and Nicotinic Acetylcholine Receptor Agonists.

Authors:  Eun Ae Kim; Kyoung Chul Jung; Uy Dong Sohn; Chaeuk Im
Journal:  Korean J Physiol Pharmacol       Date:  2009-02-28       Impact factor: 2.016

2.  Toxin-induced and genetic animal models of Parkinson's disease.

Authors:  Shin Hisahara; Shun Shimohama
Journal:  Parkinsons Dis       Date:  2010-12-22

Review 3.  Neonatal 6-hydroxydopamine lesioning of rats and dopaminergic neurotoxicity: proposed animal model of Parkinson's disease.

Authors:  Richard M Kostrzewa
Journal:  J Neural Transm (Vienna)       Date:  2022-03-12       Impact factor: 3.850

4.  Profile of Chromosomal Alterations, Chromosomal Instability and Clonal Heterogeneity in Colombian Farmers Exposed to Pesticides.

Authors:  María Paula Meléndez-Flórez; Duvan Sebastián Valbuena; Sebastián Cepeda; Nelson Rangel; Maribel Forero-Castro; María Martínez-Agüero; Milena Rondón-Lagos
Journal:  Front Genet       Date:  2022-02-24       Impact factor: 4.599

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.